Metraipolis › archive › dc_1d3f2a0dd910

Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer — Europe PMC PMID:41589227

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41589227
DOI
10.1007/s13691-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-09T11:00:42.329Z
SHA-256 of the archived text
b592ed7a435de47b9029bbe70249b35bac6288f65bda4c2d6067d8028ae0cbb7
Stable URL of this page
https://metraipolis.com/documento/dc_1d3f2a0dd910

How to cite

Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer — Europe PMC PMID:41589227 — Europe PMC (en), https://europepmc.org/article/MED/41589227 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1d3f2a0dd910 (Metraipolis archive dc_1d3f2a0dd910, sha256 b592ed7a435de47b9029bbe70249b35bac6288f65bda4c2d6067d8028ae0cbb7)
BibTeX
@misc{dc1d3f2a0dd910,
  title = {Early emergence of neuroendocrine prostate cancer during triplet therapy for high-volume metastatic castration-sensitive prostate cancer — Europe PMC PMID:41589227},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41589227},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1d3f2a0dd910; sha256 b592ed7a435de47b9029bbe70249b35bac6288f65bda4c2d6067d8028ae0cbb7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41589227. Agents can read the archived copy with the MCP tool read_document.